LCN2 and multiple sclerosis: Clinical studies have confirmed an increased level of LCN2 in the serum of patients with mild cognitive impairment (Choi et al., 2011) and in the cerebrospinal fluid of patients with multiple sclerosis (Al Nimer et al., 2016).